The Cardio-Oncology program is a premier program that strives to be at the forefront of basic, translational, and clinical research and provides the highest level of clinical care. Our goals are to translate our scientific discoveries to provide state-of-the-art, evidence-based cardiovascular care to oncology patients and survivors regionally and nationally. We work collaboratively, with our partners at the Abramson Cancer Center to help ensure that we provide comprehensive care prior to, during and after cancer treatment to minimize cardiovascular toxicities and maximize the effectiveness of cancer treatment. Our internationally-recognized research program focuses on advancing our understanding of the mechanisms of cardiovascular toxicity with cancer therapies; the identification and treatment of high risk patients, and strategies to mitigate cardiovascular risk.
Section leadership
Michael G. Fradley, MD
Medical Director, Cardio-Oncology Program
Section Chief Consultative Cardiology Program
Professor of Clinical Medicine
Bonnie Ky, MD, MSCE
Scientific Director, Cardio-Oncology Program
Director, Penn Center for Quantitative Echocardiography
Founders Professor of Cardio-Oncology
Section faculty and staff
- Benedicte Lefebvre, MD
Assistant Professor of Clinical Medicine - Rupal P. O'Quinn, MD
Associate Professor of Clinical Medicine - Marielle Scherrer-Crosbie, MD, PhD
Director of the Echocardiography Laboratory
Professor of Medicine